中介复合体亚基1,角质形成细胞,特应性皮炎,卡泊三醇,炎症反应 ," /> 中介复合体亚基1,角质形成细胞,特应性皮炎,卡泊三醇,炎症反应 ,"/> 角质形成细胞中Med1缺失对卡泊三醇诱导小鼠特应性皮炎的影响

中华皮肤科杂志 ›› 2026, e20250100.doi: 10.35541/cjd.20250100

• 论著 •    下一篇

角质形成细胞中Med1缺失对卡泊三醇诱导小鼠特应性皮炎的影响

张俊1 骆晶2 郭瑞檀2 张静豫2 黄俊凯2 李颖曦2 邢卫斌1 胡立志2,3   

  1. 1天津市中医药研究院附属医院皮肤外科,天津300070;2天津医科大学免疫微环境与疾病教育部重点实验室,天津300070;3天津医科大学第二医院眼眶研究所,天津300211

  • 发布日期:2026-10-30
  • 通讯作者: 胡立志;邢卫斌 E-mail:lizhihu@tmu.edu.cn; xingweibin111@163.com
  • 基金资助:

    国家自然科学基金(82273563,81972962,82304025)

Role of keratinocyte-specific Med1 deficiency in calcipotriol-induced AD-like dermatitis in mice

Zhang Jun1 Luo Jing2 Guo Ruitan2 Zhang Jingyu2 Huang Junkai2 Li Yingxi2 Xing Weibin1 Hu Lizhi2,3   

  1. 1Department of Dermatologic Surgery, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin, China; 2Immunology Department, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Tianjin Medical University, Tianjin, China; 3Department of Orbital Research Institute, the Second Hospital of Tianjin Medical University, Tianjin, China

  • Published:2026-10-30
  • Contact: Hu Lizhi; Xing Weibin E-mail:lizhihu@tmu.edu.cn; xingweibin111@163.com
  • Supported by:

    National Natural Science Foundation of China (82273563, 81972962,82304025)

摘要:

【摘要】目的 本研究旨在阐明Med1是否通过调控角质形成细胞中关键炎症和趋化因子的表达,从而参与特应性皮炎的发生发展。方法 将6周龄雌性野生型(Wildtype)C57BL/6J小鼠、Med1fl/fl小鼠及K14Cre-Med1fl/fl小鼠(每组6只)作为研究对象,分为对照组(乙醇)和模型组(卡泊三醇类似物,MC903)。模型组小鼠双侧耳部每日涂抹MC903乙醇溶液,连续13天,建立AD样皮炎模型。对照组涂抹等体积乙醇。首先通过免疫组化染色检测AD患者皮损组织及Wildtype模型小鼠耳部皮肤中Med1的表达水平;其次通过构建Med1fl/fl小鼠及K14Cre-Med1fl/fl小鼠的AD样炎症模型,探究角质形成细胞中Med1对AD样炎症进展的影响。H&E染色评估耳部表皮厚度及炎症细胞浸润情况;实时荧光定量PCR(qRT-PCR)检测全皮中炎症因子(IL-4、IL-6、S100A8/9)、趋化因子(CXCL1/2/3/5、CCL6/8)以及关键受体(CXCR2、ST2、CCR3)的mRNA表达水平;流式细胞术检测耳部皮肤中中性粒细胞、巨噬细胞、嗜酸性粒细胞、肥大细胞及T细胞亚群的浸润比例;分离小鼠表皮组织,利用qRT-PCR检测表皮关键炎症相关基因(IL-1β、S100A8、S100A9、CXCL2、CXCL3、CCL11)的表达情况,并通过免疫组化染色对关键炎症因子(IL-1β、CCR3、CXCL1)的表达情况进行检测;最后分离培养小鼠原代角质形成细胞,予MC903刺激后检测关键炎性因子的表达变化。对于两组间Med1的表达量,采用非配对t检验进行差异比较;多组间比较采用单因素方差分析(ANOVA)加 Tukey事后检验。结果 与正常皮肤相比,AD患者皮损组织及模型组小鼠耳部表皮中Med1表达显著上调(均P < 0.001)。与Med1fl/fl模型组小鼠相比,K14Cre-Med1fl/fl模型组小鼠耳部增厚程度显著减轻(第14天,398.70 ± 24.17 μm比238.06 ± 59.87 μm,P < 0.001),HE染色结果显示表皮厚度也显著降低(54.32 ± 6.99 μm比32.17±4.10 μm,P < 0.001)。qRT-PCR结果表明,K14Cre-Med1fl/fl小鼠全皮中炎症因子(IL-4、IL-6)、趋化因子(CCL6、CCL8)以及关键受体(ST2、CCR3)的表达水平显著低于Med1fl/fl小鼠(均P < 0.01),中性粒细胞相关炎症因子(S100A8、S100A9)和趋化因子及其受体(CXCL1、CXCL2、CXCL3、CXCL5、CXCR2)的表达也显著下调(均P < 0.001)。同时,流式细胞术进一步验证显示,Med1敲除后小鼠皮损中中性粒细胞的变化最为突出。K14Cre-Med1fl/fl模型组小鼠中性粒细胞比例显著低于Med1fl/fl模型组小鼠(15.77 ± 1.22%比5.88 ± 0.79%,P < 0.001),且其下降幅度和细胞占比均为所检测免疫细胞中最大。此外,通过分离小鼠表皮组织并联合qRT-PCR分析显示,表皮Med1缺失显著抑制多种炎症因子(IL-1β、S100A8、S100A9)和趋化因子(CXCL3、CCL11)表达(均P < 0.01),而免疫组化染色同样表明Med1缺失显著抑制表皮中IL-1β、CCR3、CXCL1的表达(均P < 0.01)。同时,体外实验进一步证实,MC903刺激原代角质形成细胞后,Med1缺失显著抑制IL-1α、CXCL1及CXCL2的mRNA表达(均P < 0.001)。结论 角质形成细胞中Med1通过调控多种关键炎症和趋化因子的表达,促进中性粒细胞的浸润,从而参与AD进展。

关键词: 中介复合体亚基1')">

中介复合体亚基1, 角质形成细胞, 特应性皮炎, 卡泊三醇, 炎症反应

Abstract:

【Abstract】Objective This study aimed to elucidate whether Med1 is involved in the development and progression of atopic dermatitis (AD) by regulating the expression of key inflammatory factors in keratinocytes. Methods Six-week-old female wildtype C57BL/6J mice, Med1fl/fl mice, and K14Cre-Med1fl/fl mice were used. Each genotype was divided into a control group (ethanol) and a model group (MC903). Mice in the model group received daily topical application of MC903 in ethanol on both ears for 13 consecutive days to establish an AD-like dermatitis model, whereas the control group received an equal volume of ethanol. First, immunohistochemical staining was performed to detect Med1 expression levels in lesional skin from patients with AD and in ear skin from MC903-treated wildtype mice. Next, AD-like dermatitis models were established in Med1fl/fl and K14Cre-Med1fl/fl mice to investigate the effect of Med1 in keratinocytes on the progression of AD-like inflammation. H&E staining was performed to evaluate epidermal thickness and inflammatory cell infiltration. Quantitative real-time PCR (qRT-PCR) was used to measure mRNA expression of inflammatory factors (IL-4, IL-6, S100A8/9), chemokines (CXCL1/2/3/5, CCL6/8), and receptors (CXCR2, ST2, CCR3) in whole skin. Histopathological staining was employed to evaluate the infiltration of neutrophils, eosinophils, mast cells, and T cells. Flow cytometry was further performed to assess the immune cell infiltration in ear skin. Mouse epidermis was isolated, and qRT-PCR was performed to detect the expression of key inflammation?related genes (IL-1β, S100A8, S100A9, CXCL2, CXCL3, CCL11), while immunohistochemical staining was used to detect the expression of IL-1β, CCR3, and CXCL1. Finally, primary mouse keratinocytes were isolated, cultured, and stimulated with MC903 to detect changes in the expression of key inflammatory factors. For comparisons of Med1 expression between two groups, an unpaired t-test was used. For comparisons among multiple groups, homogeneity of variance was tested first, followed by one-way analysis of variance (ANOVA) with Tukey’s post hoc test. Results Compared with normal skin, Med1 expression was significantly upregulated in the epidermis of AD patient lesions and MC903-treated mouse ears (P < 0.001). Compared with Med1fl/fl mice, K14Cre-Med1fl/fl mice exhibited significantly reduced ear thickness after MC903 treatment on day 14, the mean ± SD was 398.70 ± 24.17 μm for Med1fl/fl mice compared with 238.06 ± 59.87 μm for K14Cre-Med1fl/fl mice (P < 0.001). H&E staining showed decreased epidermal thickness (54.32±6.99 μm vs. 32.17±4.101 μm, P < 0.001). qRT-PCR revealed that the expression of cytokines (IL-4, IL-6), chemokines (CCL6, CCL8), and key receptors (ST2, CCR3) in whole skin of K14Cre-Med1fl/fl mice was significantly reduced compared to that in Med1fl/fl mice (all P < 0.01). The expression of neutrophil?associated mediators (S100A8, S100A9), chemokines (CXCL1, CXCL2, CXCL3, and CXCL5) and receptors (CXCR2) was also significantly downregulated (all P < 0.01). Flow cytometry further confirmed that the most prominent change in skin lesions of Med1-knockout mice was in neutrophils. The proportion of neutrophils in K14Cre-Med1fl/fl mice was significantly lower than that in Med1fl/fl mice (5.88 ± 0.79% vs. 15.77 ± 1.22%, P < 0.001), and both the magnitude of the decrease and the cell proportion were the largest among the immune cells examined. Furthermore, qRT-PCR showed that epidermal Med1 deficiency inhibited the expression of multiple inflammatory mediators (IL-1β, S100A8, S100A9) and chemokines (CXCL3, CCL11) (all P < 0.01), and immunohistochemical staining confirmed that Med1 deficiency suppressed the expression of IL-1β, CCR3, and CXCL1 in the epidermis (all P < 0.01). In vitro experiments further verified that after MC903 stimulation of primary keratinocytes, Med1 deficiency inhibited the mRNA expression of IL-1α, CXCL1, and CXCL2 (all P < 0.01). Conclusion Med1 in keratinocytes promotes neutrophil infiltration by regulating the expression of multiple key inflammatory cytokines and chemokines, thereby participating in the development and progression of AD-like dermatitis.

Key words: Mediator complex subunit 1 (Med1), Keratinocytes (KCs), Atopic dermatitis (AD), Calcipotriol (MC903), Inflammation

引用本文

张俊 骆晶 郭瑞檀 张静豫 黄俊凯 李颖曦 邢卫斌 胡立志. 角质形成细胞中Med1缺失对卡泊三醇诱导小鼠特应性皮炎的影响[J]. 中华皮肤科杂志, 2026,e20250100. doi:10.35541/cjd.20250100

Zhang Jun Luo Jing Guo Ruitan Zhang Jingyu Huang Junkai Li Yingxi Xing Weibin Hu Lizhi.

Role of keratinocyte-specific Med1 deficiency in calcipotriol-induced AD-like dermatitis in mice [J]. Chinese Journal of Dermatology,2026,e20250100. doi:10.35541/cjd.20250100